VIR Vir Biotechnology, Inc.
Healthcare$9.19+1.77%ClosedMarket Cap: $1.55B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$21.14
Target (Median)
$20.00
Target Range
$18.00 - $30.00
Upside from current price: 130.0%
Rating Distribution
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-25 | Barclays | maintain | Overweight | Overweight |
| 2026-02-24 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-24 | Needham | maintain | Buy | Buy |
| 2026-02-24 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-12-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-27 | B of A Securities | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.34 | $94.2M | 4 |
| Sun Dec 31 | $-1.67 | $150.8M | 2 |
| Mon Dec 31 | $-1.43 | $190.4M | 1 |
| Tue Dec 31 | $-1.18 | $262.8M | 1 |